The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.5M data for 728K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

11 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Design, synthesis and pharmacological characterization of analogs of 2-aminoethyl diphenylborinate (2-APB), a known store-operated calcium channel blocker, for inhibition of TRPV6-mediated calcium transport.EBI
University of Bern
High-affinity fluorescent ligands for the 5-HT(3) receptor.EBI
University of Bern
Proximity-accelerated chemical coupling reaction in the benzodiazepine-binding site of gamma-aminobutyric acid type A receptors: superposition of different allosteric modulators.EBI
University of Bern
Discovery and Structure-Activity Relationship Studies of Novel Adenosine AEBI
University of Bern
Pyrazolyl-pyrimidones inhibit the function of human solute carrier protein SLC11A2 (hDMT1) by metal chelation.EBI
University of Bern
Natural product inspired optimization of a selective TRPV6 calcium channel inhibitor.EBI
University of Bern
Photoswitchable Inhibitor of the Calcium Channel TRPV6.EBI
University of Bern
Polypharmacological profile of 1,2-dihydro-2-oxo-pyridine-3-carboxamides in the endocannabinoid system.EBI
University of Bern
Biological evaluation of pyridone alkaloids on the endocannabinoid system.EBI
University of Bern
Synthesis and structure based optimization of novel Akt inhibitors.BDB
Pfizer